Ballons ACT chez la femme : évolution de l’efficacité au cours des 24 mois suivant l’implantation

Guiffart, Pauline; Reix, B.; Martin-Malburet, Alexandre G.; Marcelli, F.; Biardeau, Xavier

doi:10.1016/j.purol.2018.09.003

Cited by 1 publication

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The mean patients’ age ranged from 62 to 83 years. Most patients had undergone at least one anti-incontinence surgery prior to ACT ® balloon implantation and four studies exclusively focused of patients with a recurrent SUI [13, 17, 19, 22]. Pure SUI accounted for 32–70% of indications, mixed SUI for 30–68%, and neurogenic SUI for 0–28% of indications.…”

Section: Resultsmentioning

confidence: 99%

“…Pure SUI accounted for 32-70% of indications, mixed SUI for 30-68%, and neurogenic SUI for 0-28% of indications. Four studies included patients with neurological diseases [11][12][13]18], while three studies excluded them [14,16,23]; data were unavailable for other studies. The proportion of patients with a history of pelvic radiation therapy ranged from 0% to 20%.…”

Section: Patients' Characteristicsmentioning

confidence: 99%

“…The operating procedure was considered easy for 48-62% of the operators, moderately difficult for 30-39%, and very difficult for 9-13% of them [16,20,23]. Outpatient procedures were reported in five studies [11,13,14,19,22]. The rate of intraoperative complications ranged from 3.5 to 25%.…”

Section: Perioperative Outcomesmentioning

confidence: 99%

See 2 more Smart Citations

Adjustable Continence Therapy Balloons in Female Patients with Stress Urinary Incontinence: A Systematic Review

2023

View full text Add to dashboard Cite

Introduction: The aim of this study was to perform a systematic review of studies reporting the outcomes of ACT® balloons in female patients with stress urinary incontinence (SUI) due to intrinsic sphincter deficiency (ISD). Methods: In accordance with PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) standards, a systematic search of the PubMed (Medline) and Scopus electronic database was performed in June 2022. Terms used for the query were (“female” or “women”) and (“adjustable continence therapy” OR “periurethral balloons”). Results: Thirteen studies were included. All were retrospective or prospective case series. The success rates ranged from 13.6% to 68% and the improvement rates from 16% to 83%. The intraoperative complication rate ranged from 3.5 to 25% and consisted of urethral, bladder, or vaginal perforations. The rate of postoperative complications varied from 11 to 56% without major complications. Between 6% and 38% of ACT® balloons were explanted and subsequently reimplanted in 15.2–63% of cases. Conclusion: ACT® balloons can be considered as an option to treat SUI due to ISD in female patients with a relatively modest success rate and quite a high complication rate. Well-designed prospective studies and long-term follow-up data are needed to fully elucidate their role.

show abstract